Case Report

Remaja pria 18 tahun dengan hipogonadotropik-hipogonadisme dan postur tubuh pendek: sebuah laporan kasus

Metanolia Sukmawati , Antonius Wahyudi, Judie Hartono, Tjahjo Djojo Tanojo

Metanolia Sukmawati
Program Pendidikan Dokter Spesialis Andrologi, Fakultas Kedokteran Universitas Airlangga/ RSUD Dr.Soetomo, Surabaya, Indonesia. Email: metanolia.sukmawati-2015@fk.unair.ac.id

Antonius Wahyudi
Program Pendidikan Dokter Spesialis Andrologi, Fakultas Kedokteran Universitas Airlangga/ RSUD Dr.Soetomo, Surabaya, Indonesia

Judie Hartono
Departemen Kedokteran Biologi, Fakultas Kedokteran, Universitas Airlangga, Surabaya, Indonesia

Tjahjo Djojo Tanojo
Departemen Kedokteran Biologi, Fakultas Kedokteran, Universitas Airlangga, Surabaya, Indonesia
Online First: December 01, 2019 | Cite this Article
Sukmawati, M., Wahyudi, A., Hartono, J., Tanojo, T. 2019. Remaja pria 18 tahun dengan hipogonadotropik-hipogonadisme dan postur tubuh pendek: sebuah laporan kasus. Intisari Sains Medis 10(3). DOI:10.15562/ism.v10i3.465


Background: Hypogonadotropic hypogonadism (HH) is congenital or acquired disease affects hypothalamus or pituitary, so the secretion of GnRH, FSH, LH, and testosterone are inadequate. Clinical manifestations both physical and psychological impair patient’s quality of life, so authors try to report this case.

Case description: An 18 years old man complained about a small penis. Small penis cause patient had introvert personality and problems in social relations. On anthropometric status, body weight was below 3rd percentile, height was below 3rd percentile, and body mass index (BMI) was thin. The genital examination was 2nd-grade tanner, penis with 3 cm length and 3 cm circumference, minimal little pubic hair, and testicular volume <2 cc. Ultrasound examination showed no presence of testes in the right or left scrotum fossa, inguinal, and lumbar region. Chromosome analysis showed 46 XY, and hormones analysis found FSH, LH, and testosterone below the normal limit. The patient was given 2000 unit HCG injection and after that FSH, LH, and testosterone hormone increase compared before HCG injections.

Conclusion: HH can impair physical and psychological patient’s quality of life through delays in sexual maturation and bone maturation. Strategies to recognize symptoms in early childhood and puberty induction on time can significantly improve the sexual and reproductive function of HH patients.

References

Swee DS, Quinton R.. Managing congenital hypogonadotrophic hypogonadism: a contemporary approach directed at optimizing fertility and long-term outcomes in males. Ther Adv Endocrinol Metab. 2019;10: 1–15.

Fraietta R, Daniel SZ, Sandro CE. Hypogonadotropic hypogonadism revisited. Clinics 2013; 68(Suppl 1):81-88.

Tsang S. When size matters: a clinical review of pathological micropenis. J Pediatr Health Care. 2010;24(4):231-240.

Boehm U, Bouloux PM, Dattani MT, de Roux N, Dodé C, Dunkel L, et al. European consensus statement on congenital hypogonadotropic hypogonadism pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2015;11(9):547–564.

Shiraishi K, Oka S, Matsuyama H. Assessment of quality of life during gonadotrophin treatment for male hypogonadotrophic hypogonadism. Clin Endocrinol (Oxf). 2014;81(2):259–265.

Beate K, Joseph N, Nicolas de R, Wolfram K. Genetics of isolated hypogonadotropic hypogonadism: role of GnRH Receptor and other genes. Int J Endocrinol. 2012; 2012:1-9.

Marino M, Moriondo V, Vighi E, Pignatti E, Simoni M. Central hypogonadotropic hypogonadism: genetic complexity of a complex disease. Int J Endocrinol. 2014;2014:1-13.

Bianco SD, Kaiser UB. The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism. Nat Rev Endocrinol. 2009;5(10):569–576.

Oh JK, Im YJ, Park K, Paick JS. Effects of combined growth hormone and testosterone treatments in a rat model of micropenis. Endocr Connect. 2018;7(11):1150–1157.

Maione L, Dwyer AA, Francou B, Guiochon-Mantel A, Binart N, Bouligand J, et al. Genetic counseling for congenital hypogonadotropic hypogonadism and Kallmann syndrome: new challenges in the era of oligogenism and next generation sequencing. Eur J Endocrinol. 2018;178(3):R55–R80.

Han TS, Bouloux PM. What is the optimal therapy for young males with hypogonadotropic hypogonadism ? Clin Endocrinol (Oxf). 2010;72(6):731-737.

Wiygul J, Lane SP. Micropenis. Scientific World Journal 2011;11:1462–1469.

Hatipoğlu N, Kurtoğlu S. Micropenis: etiology, diagnosis and treatment approaches. J Clin Res Pediatr Endocrinol. 2013;5(4):217-223.

Thirumalai A, Berkseth KE, Amory JK. Treatment of hypogonadism: current and future therapies. F1000 research. 2017;6:68.


No Supplementary Material available for this article.
Article Views      : 191
PDF Downloads : 94